{"id":152674,"date":"2023-08-10T16:30:37","date_gmt":"2023-08-10T20:30:37","guid":{"rendered":"https:\/\/44.250.171.167\/?p=152674"},"modified":"2023-08-10T16:30:38","modified_gmt":"2023-08-10T20:30:38","slug":"orchid-pharma-ltd-q1fy24-40-rise-in-revenue","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/orchid-pharma-ltd-q1fy24-40-rise-in-revenue\/","title":{"rendered":"Orchid Pharma Ltd Q1FY24; 40% rise in Revenue"},"content":{"rendered":"\n<p>Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Financial Results:<\/h2>\n\n\n\n<p>Orchid Pharma Ltd reported Revenues for Q1FY24 of \u20b9182.92 Crores up from \u20b9130.99 Crore year on year, a rise of 39.64%.<\/p>\n\n\n\n<p>Total Expenses for Q1FY24 of \u20b9174.04 Crores up from \u20b9148.01 Crores year on year, a rise of 17.59%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b99.40 Crores from -\u20b915.01 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b91.85, from -\u20b93.68 in the same quarter of the previous year.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667-839x1024.png\" alt=\"\" class=\"wp-image-152675\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-667.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/a><\/figure><\/div>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. Financial Results: Orchid Pharma Ltd reported Revenues for Q1FY24 of \u20b9182.92 Crores up from \u20b9130.99 Crore year on year, a rise of 39.64%. Total Expenses [&hellip;]<\/p>\n","protected":false},"author":1885,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,5747],"tags":[10162],"class_list":["post-152674","post","type-post","status-publish","format-standard","hentry","category-infographics","category-healthcare-stocks","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":156573,"url":"https:\/\/alphastreet.com\/india\/orchid-pharma-ltd-q2fy24-21-rise-in-revenue\/","url_meta":{"origin":152674,"position":0},"title":"Orchid Pharma Ltd Q2FY24; 21% rise in Revenue","author":"Hardik Bhandare","date":"November 22, 2023","format":false,"excerpt":"Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. Financial Results: Orchid Pharma Ltd reported Revenues for Q2FY24 of \u20b9199.00 Crores up from \u20b9165.00 Crore year on year, a\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-294.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":145782,"url":"https:\/\/alphastreet.com\/india\/orchid-pharma-limited-q4fy23-earnings-story\/","url_meta":{"origin":152674,"position":1},"title":"Orchid Pharma Limited Q4FY23 Earnings Story","author":"Karan_Singh","date":"May 11, 2023","format":false,"excerpt":"Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. Financial Results: Orchid Pharma Ltd. reported Total Income for Q4FY23 of \u20b9 212 Crores up from \u20b9 180 Crore year\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":153513,"url":"https:\/\/alphastreet.com\/india\/marksans-pharma-ltd-q1fy24-17-rise-in-profits\/","url_meta":{"origin":152674,"position":2},"title":"Marksans Pharma Ltd Q1FY24; 17% rise in Profits","author":"Karan_Singh","date":"August 14, 2023","format":false,"excerpt":"Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for Q1FY24 of \u20b9500.00 Crores up from \u20b9434.00 Crore year on year, a rise of 15.21%. Total Expenses for Q1FY24 of \u20b9414.00 Crores up from \u20b9374.00 Crores year on year, a\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-943.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-943.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-943.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-943.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-943.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-943.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152066,"url":"https:\/\/alphastreet.com\/india\/natco-pharma-ltd-q1fy24-31-rise-in-profits\/","url_meta":{"origin":152674,"position":3},"title":"Natco Pharma Ltd Q1FY24; 31% rise in Profits","author":"Karan_Singh","date":"August 9, 2023","format":false,"excerpt":"NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.NATCO has established its presence in all three business segments viz. finished dosage formulations (\u201cFDF\u201d), active pharmaceutical ingredients (\u201cAPIs\u201d), Contract Manufacturing Business. Financial Results: Natco\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-464.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-464.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-464.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-464.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-464.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-464.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":150232,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q1fy24-19-rise-in-profits\/","url_meta":{"origin":152674,"position":4},"title":"Ajanta Pharma Ltd Q1FY24; 19% rise in Profits.","author":"Divyansh_Kasana","date":"July 27, 2023","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported Revenues for Q1FY24 of \u20b91,021.00 Crores up from \u20b9951.00 Crore year on year, a rise of 7.36%. Total Expenses for Q1FY24 of \u20b9784.00 Crores up from \u20b9762.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-320.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":154136,"url":"https:\/\/alphastreet.com\/india\/astrazeneca-pharma-india-ltd-q1fy24-170-rise-in-profits\/","url_meta":{"origin":152674,"position":5},"title":"Astrazeneca Pharma India Ltd Q1FY24; 170% rise in Profits","author":"Divyansh_Kasana","date":"August 16, 2023","format":false,"excerpt":"AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India Ltd reported Revenues for Q1FY24 of \u20b9295.00 Crores up from \u20b9232.00 Crore year on year, a rise of 27.16%. Total Expenses for Q1FY24 of \u20b9232.00 Crores up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1144.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1144.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1144.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1144.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1144.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1144.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/152674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1885"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=152674"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/152674\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=152674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=152674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=152674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}